These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 8849078)
1. [Responses to triple viral and tetanus vaccination in HIV-infected children]. Echeverría Lecuona J; Aldamiz-Echevarría Azuara L; Cilla Eguiluz G; Pérez Trallero E An Esp Pediatr; 1996 Apr; 44(4):317-20. PubMed ID: 8849078 [TBL] [Abstract][Full Text] [Related]
2. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
3. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Dennehy PH; Saracen CL; Peter G Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862 [TBL] [Abstract][Full Text] [Related]
4. Measles immunity in HIV-infected children. Walter EB; Katz SL; Bellini WJ Pediatr AIDS HIV Infect; 1994 Oct; 5(5):300-4. PubMed ID: 11361371 [TBL] [Abstract][Full Text] [Related]
5. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. King SM; Saunders EF; Petric M; Gold R Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine. Just M; Berger R; Just V Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863 [TBL] [Abstract][Full Text] [Related]
7. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126 [TBL] [Abstract][Full Text] [Related]
8. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium. Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877 [TBL] [Abstract][Full Text] [Related]
9. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection. Brunell PA; Vimal V; Sandu M; Courville TM; Daar E; Israele V J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):540-8. PubMed ID: 8548333 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus. Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112 [TBL] [Abstract][Full Text] [Related]
11. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. Should we be concerned? Watada B; Kennedy K; Chan D; Church B; Patriquin M; Shariff F; Evans MF Can Fam Physician; 1998 Jan; 44():53-5. PubMed ID: 9481462 [No Abstract] [Full Text] [Related]
12. Measles, mumps and rubella immunisation in children at risk of infection with human immunodeficiency virus. Molyneaux PJ; Mok JY; Burns SM; Yap PL J Infect; 1993 Nov; 27(3):251-3. PubMed ID: 8308316 [TBL] [Abstract][Full Text] [Related]
13. [Mumps epidemic in vaccinated children in West Switzerland]. Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells. Just M; Berger R; Glück R; Wegmann A Dev Biol Stand; 1986; 65():25-7. PubMed ID: 3549399 [TBL] [Abstract][Full Text] [Related]
15. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine. André FE; Peetermans J Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770 [TBL] [Abstract][Full Text] [Related]
16. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland. Narayan KM; Moffat MA Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895 [TBL] [Abstract][Full Text] [Related]
17. Revaccination of children after completion of standard chemotherapy for acute leukemia. Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052 [TBL] [Abstract][Full Text] [Related]
18. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276 [TBL] [Abstract][Full Text] [Related]
19. Immunization status of children born to human immunodeficiency virus (HIV)-infected mothers in two Texas cities. Schulte JM; Burkham S; Squires JE; Doran T; Hamaker DW; Pelosi J; Graper J; Davis R; Caldwell MB South Med J; 2000 Jan; 93(1):48-52. PubMed ID: 10653065 [TBL] [Abstract][Full Text] [Related]
20. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]